Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05975554
NA

The Effect of Low-dose Interleukin-2 on the Immune Landscape of Human Atherosclerotic Plaques at Single Cell Resolution.

Sponsor: Cambridge University Hospitals NHS Foundation Trust

View on ClinicalTrials.gov

Summary

The goal of this clinical trail is to compare the differences in carotid plaque Treg cells' gene signature for activation, proliferation, and suppressive function using scRNA-seq in patients treated with IL-2 compared to control.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2023-08-26

Completion Date

2025-09-01

Last Updated

2025-05-30

Healthy Volunteers

No

Interventions

DRUG

Interleukin-2 [IL-2]

5 sequential days of treatment (1.5MIU/day subcutaneously)

PROCEDURE

Standard care - Carotid Endarterectomy

Standard care for patients with carotid stenosis undergoing carotid endarterectomy

Locations (1)

Addenbrookes Hospital

Cambridge, Cambridgeshire, United Kingdom